Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $43,913 - $48,718
-188 Closed
0 $0
Q1 2021

May 04, 2021

BUY
$221.91 - $258.6 $18,196 - $21,205
82 Added 77.36%
188 $47,000
Q4 2020

Mar 02, 2021

BUY
$216.38 - $257.67 $22,936 - $27,313
106 New
106 $24,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Grant Street Asset Management, Inc. Portfolio

Follow Grant Street Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grant Street Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grant Street Asset Management, Inc. with notifications on news.